JPS57209229A - Production of immune complex antiserum for carcinostatic purpose - Google Patents
Production of immune complex antiserum for carcinostatic purposeInfo
- Publication number
- JPS57209229A JPS57209229A JP6526581A JP6526581A JPS57209229A JP S57209229 A JPS57209229 A JP S57209229A JP 6526581 A JP6526581 A JP 6526581A JP 6526581 A JP6526581 A JP 6526581A JP S57209229 A JPS57209229 A JP S57209229A
- Authority
- JP
- Japan
- Prior art keywords
- complex
- antiserum
- antibody
- glycovaccine
- produce
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
PURPOSE: A glycovaccine is injected into an animal to produce an antibody, its blood is collected, then the serum fraction and the glycovaccine are mixed to form a complex, centrifuged and the complex is dispersed in water to produce the high-purity titled antiserum in a large amount.
CONSTITUTION: A glycovaccine is injected with a injector 2-1 into the animal body 20-1 to produce the antibody 1-1 and the blood containing the antibody is collected in capsule 3. Its serum fraction is mixed with glycovaccine 1-2 and they are centrifuged to cause the antigen-antibody reaction, resulting in separation of the complex 1. The supernatant is removed in 3, then the complex is dispersed in water to give the antiserum 1. In general, serum is a part of antibody, but in cancers, the film of the complex is formed through the glycoantigen on the surface of the cancer cells, whereby the aqueous solution of the complex becomes the antiserum. The use of blood-collecting capsules permits the germ-free production of the objective antiserum in an inductrial scale.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6526581A JPS57209229A (en) | 1981-05-01 | 1981-05-01 | Production of immune complex antiserum for carcinostatic purpose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6526581A JPS57209229A (en) | 1981-05-01 | 1981-05-01 | Production of immune complex antiserum for carcinostatic purpose |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS57209229A true JPS57209229A (en) | 1982-12-22 |
Family
ID=13281909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6526581A Pending JPS57209229A (en) | 1981-05-01 | 1981-05-01 | Production of immune complex antiserum for carcinostatic purpose |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57209229A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4740371A (en) * | 1984-09-17 | 1988-04-26 | International Institute Of Cellular And Molecular Pathology | Treatment of allergy |
US5026545A (en) * | 1984-09-17 | 1991-06-25 | Baxter International, Inc. | Treatment of allergy and composition therefor |
US5543145A (en) * | 1984-09-17 | 1996-08-06 | Baxter International, Inc. | Pharmaceutical composition and method for the suppression of factor VIII inhibitor production |
-
1981
- 1981-05-01 JP JP6526581A patent/JPS57209229A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4740371A (en) * | 1984-09-17 | 1988-04-26 | International Institute Of Cellular And Molecular Pathology | Treatment of allergy |
US5026545A (en) * | 1984-09-17 | 1991-06-25 | Baxter International, Inc. | Treatment of allergy and composition therefor |
US5543145A (en) * | 1984-09-17 | 1996-08-06 | Baxter International, Inc. | Pharmaceutical composition and method for the suppression of factor VIII inhibitor production |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brody et al. | Anxiety and ego formation in infancy. | |
JPS5375321A (en) | Production of specific immune nucletic acid cell dialysate and antibody | |
Kurien | A modification to the ferrioxalate actinometer | |
JPS57120518A (en) | Preparation of microcapsule | |
ATE34746T1 (en) | AQUEOUS PREPARATION CONTAINING VITAMIN E. | |
JPS57209229A (en) | Production of immune complex antiserum for carcinostatic purpose | |
ATE63236T1 (en) | MAGNETIC MEMBRANE CAPSULES AND THEIR USE. | |
JPS5530655A (en) | Latex sensitive to human igg antibody for quantitizing human igg and its particle composite | |
IL66959A0 (en) | Immune complex removal and tumor specific antibody generation by immobilized protein a perfusion and postperfusion drug infusion | |
JPS5423119A (en) | Erythrocyte for haemagglutination test | |
JPS51148457A (en) | Increment and decrement detector of upper-layer liquid | |
JPS559033A (en) | Medical capsule | |
JPS56125667A (en) | Reagent for measurement and measuring method for human muscle type aldolase | |
JPS56158165A (en) | Liquid separating tube | |
Grandics | Immobilization of proteins (antibodies) to supports with a constantly high retention of immunoreactivity involving the formation of a Schiff-base and subsequent reduction to a secondary amine with sodium borohydride or sodium cyanoborohydride has been problematical | |
USD213292S (en) | Sputum collecting device | |
JPS5666759A (en) | Measuring tube for radioimmunoassay used for clinical inspection | |
EP0052645A4 (en) | Gamma-emitting receptor-binding quinuclidinyl benzilates methods of preparation thereof and imaging and assay methods utilizing same. | |
JPS5336243A (en) | Pressure sensitive adhesive electrophotographic toner | |
Brochmann-Hanssen et al. | Biosynthesis of magnoflorine from reticuline by direct oxidative coupling | |
GB1276205A (en) | Particulate complexes of copper-64 and gelatin, and their preparation | |
JPS5616415A (en) | Preparation of antibody | |
Moss et al. | Synthesis of annelated 1, 3, 4, 6-thiatriazepines from dichlorodiazabutadienes and cyclic thioureas | |
USD224026S (en) | Automatic ticket examining device | |
Javadpour | Re: red cell surface antigen and its relationship to survival of patients with transitional cell carcinoma of the bladder, Asghar Askari, Enrique Colmenares, Akiko Saberi and W. Dabney Jarman, J. Urol., 125: 182-184, 1981 |